Table 1:
Demographics and Oncologic Characteristics
| Variables | TNT % (n) | SAND % (n) | p Value |
|---|---|---|---|
| Total | 43% (34) | 57% (45) | |
| Gender | 0.77 | ||
| Male | 45% (15) | 47% (21) | |
| Female | 55% (19) | 53% (24) | |
| Age (mean ± std) | 52.6 ± 8.3 | 49.1 ± 6.4 | 0.34 |
| Race | 0.67 | ||
| White | 65% (22) | 71% (32) | |
| Black | 24% (8) | 20% (9) | |
| Other | 11% (4) | 9% (4) | |
| BMI (mean ± std) | 29.8 ± 4.2 | 27.2 ± 3.9 | 0.79 |
| ASA Class | 0.82 | ||
| 1 | 0% (0) | 0% (0) | |
| 2 | 14.7% (5) | 20% (9) | |
| 3 | 82.4% (28) | 77.8% (35) | |
| 4 | 2.9% (1) | 2.2% (1) | |
| ECOG Performance Status | 0.31 | ||
| 0 | 38.2% (13) | 44.5% (20) | |
| 1 | 29.4% (10) | 28.9% (13) | |
| 2 | 0% (0) | 4.4% (2) | |
| 3 | 0% (0) | 2.2% (1) | |
| Unknown | 32.4% (11) | 20% (9) | |
| Peritoneal Surface Disease Severity Score (mean ± std) | 8.5 ± 3.3 | 8.2 ± 2.1 | 0.69 |
| Charlson Comorbidity Index (mean ± std) | 6.6 ± 0.8 | 6.7 ± 0.5 | 0.91 |
| Synchronous Disease | 32% (11) | 36% (16) | 0.81 |
| Time between primary resection and diagnosis of CPM (mean ± std) | 19.30 ± 3.8 months | 17.5± 5.2 months | 0.16 |
| Lymph Node Positivity | 83.3% (28) | 66.7% (30) | 0.12 |
| Liver Metastases | 16.7% (6) | 17.8% (8) | 0.98 |
| Tumor Location | 0.98 | ||
| Colon | 94.1% (32) | 93.3% (42) | |
| Rectum | 5.9% (2) | 6.7% (3) | |
| Tumor Grade | 0.17 | ||
| High-grade | 64.7% (22) | 47% (21) | |
| Intermediate Grade | 35.3% (12) | 53% (24) | |
| Lymphovascular Invasion | 41.2% (14) | 42.2% (19) | 0.99 |
| Perineural Invasion | 35.3% (12) | 31.1% (14) | 0.81 |